ibrutinib price in 2023
Ibrutinib (Ibrutinib) is an oral anti-cancer drug that belongs to a class of drugs called BTK inhibitors.
Ibrutinib is currently on the market in China and is included in medical insurance. The domestic price ranges from 10,000 to 20,000. Due to different medical insurance policies in different places, the price is also different. For specific reimbursement information, please consult the local hospital pharmacy or medical insurance bureau. The cheaper types of ibrutinib abroad are generic drugs, mainly Indian generic drugs, Bangladeshi generic drugs and Laos generic drugs, with prices ranging from a few hundred to several thousand yuan. And the ingredients of generic ibrutinib drugs are basically the same as those of domestic ibrutinib drugs.
Ibrutinib is mainly used to treat specific types of blood cancers and lymphomas, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL) and mucosa-associated lymphoid tissue lymphoma (MALTlymphoma). It is often used in patients who have previously received other treatments but failed to achieve adequate relief.

The main effect of ibrutinib is to target malignant cells of leukemia and lymphoma by inhibiting BTK activity in B lymphocytes. BTK is a tyrosine kinase that plays a key role in the normal development and activation of B lymphocytes. However, in some blood cancers and lymphomas, BTK is overactivated, leading to abnormal proliferation of cancer cells. Ibrutinib interferes with this signaling pathway by inhibiting BTK, thereby effectively controlling the growth of these cancer cells.
Ibrutinib is usually taken by mouth once daily. Patients should take the medication in specific dosages as prescribed and recommended by their doctor. Dosage may vary based on the patient's specific condition.
Ibrutinib may cause a series of side effects, including but not limited to bleeding tendencies, high blood pressure, abnormal liver function, fatigue, gastrointestinal discomfort, skin reactions, etc. Patients should pay close attention to any side effects and report them to their doctor promptly.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)